Perrigo Co. Stock Hits Day Low of $15.05 Amid Price Pressure

Perrigo Co. Plc, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 15.05. The company has reported a notable decline of -25.21% in its stock price, contrasting sharply with the S&P 500's modest decline of -1.17% for the same period.
Over the past week, Perrigo's performance has been similarly challenging, with a drop of -29.04%, and a staggering -32.92% over the last month. Year-to-date, the stock has plummeted by -41.27%, while its one-year performance shows a decline of -40.43%. This consistent underperformance is evident when compared to the S&P 500, which has gained 18.54% over the same timeframe.

Financial metrics indicate a concerning trend for Perrigo, with a net profit of USD -67.46 million reflecting a significant decline of -202.37%. Additionally, the pre-tax profit for the latest quarter has fallen by -90.52%. The company's debt-to-equity ratio stands at 0.72, and it has a return on equity of 0.37%, further highlighting the challenges it faces in the current market environment.